Gladpharm Limited Pharmaceutical Import Profile — Ukraine (DGFT 2022–2026)

Name: Gladpharm Limited Pharmaceutical Import Records from India — 9 Products, $6.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Gladpharm Limited — Pharmaceutical Importer Profile (2026) | 9 Products, $6.5M Trade | TransData Nexus

Gladpharm Limited

Pharmaceutical Importer · Ukraine · Antifungals Focus · $6.5M Total Trade · DGFT Verified

Gladpharm Limited is a pharmaceutical importer based in Ukraine with a total trade value of $6.5M across 9 products in 6 therapeutic categories. Based on 319 verified import shipments from Indian Customs (DGFT) records, Gladpharm Limited is the #1 buyer in 1 product including Biotin. Gladpharm Limited sources from 1 verified Indian supplier, with Kusum Healthcare Private Limited accounting for 100.0% of imports.

Gladpharm Limited — Import Portfolio & Supplier Network

Gladpharm Limited import network — 9 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Gladpharm Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Kusum Healthcare Private Limited	$6.3M	405	100.0%

Gladpharm Limited sources from 1 verified Indian supplier across 328 distinct formulations. The sourcing is highly concentrated — Kusum Healthcare Private Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Gladpharm Limited Import?

Formulation	Value	Ships
Fanigan tablet 10x10s	$100.8K	3
Zonik-150 capsules 2x14s pregabalin	$77.9K	4
Wolvit-1% shampoo 200 ML( biotin shampoo1% w/w)bno. 100303130323134dom01.2024doe12.2025 or bno.	$72.2K	3
Wolvit-1% shampoo 200 ML( biotin shampoo1% w/w )bno.1001871 or 1882 dom08.2023	$70.6K	2
Fusys-150 tablets 1x1s(fluconazole 150mgtablets	$67.5K	3
Bactopic ointment 15GM mupirocin ointment BP 2% bno.2007842dom 04.2023doe	$66.8K	2
Piritan tablets 1.0 MG	$64.1K	3
Fusys-100 tablets 1x10s(fluconazole 100MG tablets	$63.0K	3
Diclosafe forte emulsion gel 50 g( diclofenac diethylamine emulsion gel 2.32% w/w )bno.100317531763177or	$62.1K	3
Zonik-75 capsule 2x14spregabalin capsules 75mgbno.	$61.3K	2
Nimid gel 100 gmnimesulide 1% w/w gelbno.20077177718 or	$59.6K	2
Zonik-75 capsule 2x14s(pregabalin capsules 75MG)bno.1002870 or	$59.4K	3
Polymic tablets 1x10s	$58.8K	2
Zonik-25 capsules 2x14s pregabalin	$52.7K	3
Serrata tablets 5x30s	$51.0K	5

Import Portfolio — Top 9 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ketoconazole	Antifungals	$2.0M	145	3.5%	6
2	Clotrimazole	Antifungals	$1.1M	56	1.2%	9
3	Levofloxacin	Antibiotics	$1.1M	22	1.5%	6
4	Pyrantel	Antimalarial & Antiparasitic	$818.5K	27	12.8%	2
5	Biotin	Vitamins & Supplements	$745.0K	26	25.2%	1
6	Miconazole	Antifungals	$354.0K	17	1.8%	8
7	Leflunomide	Immunosuppressants	$225.5K	9	1.5%	14
8	Secnidazole	Advanced Antibiotics	$112.3K	15	0.4%	16
9	Gatifloxacin	Advanced Antibiotics	$77.0K	2	9.6%	4

Gladpharm Limited imports 9 pharmaceutical products across 6 categories into Ukraine totaling $6.5M. The company is the #1 buyer for 1 product: Biotin.

Gladpharm Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Gladpharm Limited is a Ukrainian pharmaceutical company specializing in the importation and distribution of finished pharmaceutical formulations. Headquartered in Kyiv, Ukraine, at Alma-Atynska Street 58, the company plays a pivotal role in supplying a diverse range of medicinal products to the Ukrainian market. Established in 1996, Gladpharm Limited has developed a robust infrastructure, including a certified production facility in Sumy, Ukraine, compliant with international Good Manufacturing Practice (GMP) standards.

The company's product portfolio encompasses over 100 registered medicinal products across various therapeutic areas, such as cardiovascular diseases, gastrointestinal disorders, and endocrine diseases, including diabetes. This extensive range underscores Gladpharm Limited's commitment to addressing the most pressing public health needs in Ukraine.

2Distribution Network

Gladpharm Limited's distribution network is strategically designed to ensure efficient delivery of pharmaceutical products throughout Ukraine. The company operates a modern logistics and manufacturing complex near Kyiv, equipped with state-of-the-art storage, monitoring, and environmental safety systems. This facility, launched in 2025, enhances the company's ability to manage inventory effectively and meet the demands of the Ukrainian healthcare sector.

While specific details about additional warehouse locations and logistics capabilities are not publicly disclosed, Gladpharm Limited's infrastructure indicates a well-organized distribution system capable of serving the entire Ukrainian market. The company's commitment to quality and safety is evident in its adherence to international standards, ensuring that products are stored and transported under optimal conditions.

3Industry Role

In Ukraine's pharmaceutical supply chain, Gladpharm Limited functions primarily as a pharmaceutical importer and distributor. The company sources finished pharmaceutical formulations from international suppliers, notably Kusum Healthcare Private Limited in India, and distributes these products to various stakeholders within the Ukrainian healthcare system. This role is crucial in ensuring the availability of a wide range of medicinal products to meet the diverse needs of patients across the country.

Gladpharm Limited's position as a key importer and distributor underscores its significant contribution to the Ukrainian pharmaceutical sector. By maintaining a diverse product portfolio and a robust distribution network, the company plays a vital role in enhancing the accessibility and quality of healthcare in Ukraine.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Gladpharm Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Gladpharm Limited's sourcing strategy exhibits a high degree of concentration, with a total import value of $6.5 million USD from India, accounting for 100% of its pharmaceutical imports. This sourcing pattern indicates a strategic partnership with Kusum Healthcare Private Limited, which has supplied all 319 shipments of finished pharmaceutical formulations to Gladpharm Limited. (en.nbd.ltd)

The company's top five imported products—Biotin, Pyrantel, Ketoconazole, Clotrimazole, and Levofloxacin—collectively represent 88.2% of the total import value. This concentration suggests a focused product strategy, potentially aimed at addressing specific therapeutic needs within the Ukrainian market. However, such reliance on a single supplier and a narrow product range may expose Gladpharm Limited to risks related to supply chain disruptions, pricing fluctuations, and changes in regulatory policies affecting its primary supplier.

To mitigate these risks, it would be prudent for Gladpharm Limited to consider diversifying its supplier base and expanding its product portfolio. Engaging with additional suppliers and incorporating a broader range of products could enhance the company's resilience and adaptability in the dynamic pharmaceutical market.

2Supply Chain Resilience

Gladpharm Limited's supply chain resilience is closely tied to its exclusive partnership with Kusum Healthcare Private Limited in India. This singular sourcing arrangement may pose challenges in terms of supply chain continuity, especially in the event of disruptions such as geopolitical tensions, natural disasters, or regulatory changes affecting the primary supplier.

Importing Pharmaceuticals into Ukraine — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Ukraine

1Regulatory Authority & Framework

In Ukraine, the State Service of Ukraine for Medicines and Drugs Control (SMDC) is the primary regulatory authority overseeing the pharmaceutical sector. The SMDC is responsible for issuing licenses for the production, import, wholesale, and retail trade of medicinal products. Importers must comply with the Licensing Conditions approved by the Cabinet of Ministers of Ukraine, which include maintaining a pharmaceutical quality system that incorporates applicable Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) elements. (dls.gov.ua)

Key legislation governing pharmaceutical imports includes the Law of Ukraine on Medicinal Products and the Law of Ukraine on Licensing of Certain Types of Economic Activity. These laws establish the framework for the registration, importation, and distribution of medicinal products, ensuring that imported medicines meet the required quality and safety standards.

The marketing authorization pathway for Indian generics involves obtaining a marketing authorization from the SMDC, which requires compliance with Ukrainian regulatory standards, including GMP certification and quality control procedures. Additionally, parallel importation of medicines is permitted under specific conditions, allowing for the import of medicines identical or similar to those registered in Ukraine from countries such as the EU, Iceland, Liechtenstein, and Norway. (cms.law)

2Import Licensing & GMP

Frequently Asked Questions — Gladpharm Limited

What products does Gladpharm Limited import from India?

Gladpharm Limited imports 9 pharmaceutical products across 6 categories. Top imports: Ketoconazole ($2.0M), Clotrimazole ($1.1M), Levofloxacin ($1.1M), Pyrantel ($818.5K), Biotin ($745.0K).

Who supplies pharmaceuticals to Gladpharm Limited from India?

Gladpharm Limited sources from 1 verified Indian suppliers. The primary supplier is Kusum Healthcare Private Limited (100.0% of imports, $6.3M).

What is Gladpharm Limited's total pharmaceutical import value?

Gladpharm Limited's total pharmaceutical import value from India is $6.5M, based on 319 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Gladpharm Limited focus on?

Gladpharm Limited imports across 6 categories. The largest: Antifungals (52.6%), Antibiotics (16.9%), Antimalarial & Antiparasitic (12.6%).

Get Full Gladpharm Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 3 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

Gladpharm Limited

Gladpharm Limited — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Gladpharm Limited?

What Formulations Does Gladpharm Limited Import?

What Products Does Gladpharm Limited Import?

Top Products by Import Value

Gladpharm Limited Therapeutic Categories — 6 Specializations